To explore the possibility that CD44+/CD24– population bears cancer stem cell-like property, we examined the correlation between HER2 and CD44+/CD24– population by overexpressing or knocking down HER2 in different ovarian cancer cell lines. The gene discussed is CD44; the disease is ovarian carcinoma.